MP Biomedicals Asia Pacific announces the successful development of the ASSURE SARS-CoV-2 IgG/IgM rapid test, a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR). It produces accurate results in as little as 15 min and employs a lateral flow format similar to those used in home pregnancy tests. The test kit detects immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies, which are produced by the body to combat SARS-CoV-2, from samples of human blood, plasma, or serum. ASSURE should not be used in the clinical diagnosis of COVID-19 infections or in the evaluation of persons with acute respiratory symptoms, especially within the first 14 days of illness. However, ASSURE can help to determine whether an individual has been previously exposed to the virus and has generated antibodies as a result. This can help identify asymptomatic individuals or those with only mild symptoms who were not subjected to reverse transcription-PCR testing.